EPIQ CVxi Diagnostic Ultrasound Systems, Product Code: 795232

FDA Device Recall #Z-0123-2022 — Class II — September 21, 2021

Recall Summary

Recall Number Z-0123-2022
Classification Class II — Moderate risk
Date Initiated September 21, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Ultrasound Inc
Location Bothell, WA
Product Type Devices
Quantity 107

Product Description

EPIQ CVxi Diagnostic Ultrasound Systems, Product Code: 795232

Reason for Recall

Ultrasound system software issue can cause an EchoNavigator error notification, leading to an unresponsive system, necessitating system restart, which could lead to therapy/treatment delay and/or unnecessary therapy/treatment. Can occur during ultrasound-guided TEE with EchoNavigator, if secondary screen capture is enabled and user presses other system buttons before secondary capture completed.

Distribution Pattern

US: MI, AZ, IA, TN, OH, CO, WI, NY, NJ, NC, LA, IL, CA, KY, IN, MD, TX, PA. OUS: Denmark, Latvia, Belgium, Hungary, Argentina, Canada, Spain, Germany, Greece, Korea, Republic of Japan, France, Australia, Egypt, Switzerland, Italy, Senegal, Israel, Indonesia, Netherlands, Hong Kong, United Kingdom, Poland, Finland, India, New Zealand

Lot / Code Information

Software Versions: 6.0, 7.0, 7.0.3

Other Recalls from Philips Ultrasound Inc

Recall # Classification Product Date
Z-0070-2022 Class II Philips Ultrasound, Inc. Sparq, Diagnostic Ultr... Aug 19, 2021
Z-0071-2022 Class II Philips Ultrasound, Inc. Sparq, Diagnostic Ultr... Aug 19, 2021
Z-2483-2021 Class II EPIQ Diagnostic Ultrasound Systems: Software... Aug 6, 2021
Z-2484-2021 Class II Affiniti Diagnostic Ultrasound Systems: Soft... Aug 6, 2021
Z-2306-2021 Class II EPIQ Ultrasound Systems, Model: EPIQ Elite, EPI... Jul 22, 2021

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.